Back to today’s briefing

Story perspectives

Colossal Biosciences Aims to Revive Woolly Mammoth and Dodo

1/28/2025

50 11

Summary

Story summary

Colossal Biosciences, a Dallas-based pioneer, is on a bold mission to bring back the woolly mammoth and dodo through cutting-edge CRISPR technology. Valued at over $10 billion, the company grapples with ethical dilemmas surrounding ecological balance and animal welfare, all while aiming to combat climate change and restore biodiversity through its revolutionary de-extinction initiatives.

1 of 1

Story summary

Colossal Biosciences, a Dallas-based pioneer, is on a bold mission to bring back the woolly mammoth and dodo through cutting-edge CRISPR technology. Valued at over $10 billion, the company grapples with ethical dilemmas surrounding ecological balance and animal welfare, all while aiming to combat climate change and restore biodiversity through its revolutionary de-extinction initiatives.